NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

212 hedge funds and large institutions have $3.44B invested in Neurocrine Biosciences in 2016 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 85 increasing their positions, 75 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
212
Holders Change
-6
Holders Change %
-2.75%
% of All Funds
5.66%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.24%
New
35
Increased
85
Reduced
75
Closed
37
Calls
$22.7M
Puts
$16.2M
Net Calls
+$6.55M
Net Calls Change
-$1.51M

Top Buyers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$65.3M
2
HM
2
HealthCor Management
New York
$28.7M
3
Citadel Advisors
3
Citadel Advisors
Florida
$71.7M
4
First Trust Advisors
4
First Trust Advisors
Illinois
$25.2M
5
Goldman Sachs
5
Goldman Sachs
New York
$31M

Top Sellers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$0
2
PC
2
PointState Capital
New York
$0
3
RIM
3
RS Investment Management
California
$439K
4
CCI
4
Columbus Circle Investors
$7.16M
5
VAM
5
Visium Asset Management
New York
$73.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
HM
26
HealthCor Management
New York
$28.7M +$28.7M +725,000 New
Norges Bank
27
Norges Bank
Norway
$28.4M -$1.26M -31,894 -4%
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$26M +$4.06M +102,630 +19%
First Trust Advisors
29
First Trust Advisors
Illinois
$25.2M +$25.2M +638,287 New
UBS AM
30
UBS AM
Illinois
$24.8M +$652K +16,498 +3%
CAM
31
Cormorant Asset Management
Massachusetts
$23.9M – – –
VOYA Investment Management
32
VOYA Investment Management
Georgia
$22.1M +$961K +24,300 +5%
O
33
OppenheimerFunds
New York
$20.7M +$8.79M +222,222 +74%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$18.3M +$2.15M +54,345 +13%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$17.9M +$312K +7,885 +2%
Wellington Management Group
36
Wellington Management Group
Massachusetts
$16.6M -$109K -2,750 -0.7%
ACA
37
Avoro Capital Advisors
New York
$16M +$11M +278,320 +219%
RSCM
38
Rock Springs Capital Management
Maryland
$16M +$1.07M +27,000 +7%
Charles Schwab
39
Charles Schwab
California
$15.7M +$2.52M +63,804 +19%
Jennison Associates
40
Jennison Associates
New York
$14.6M -$4.92M -124,367 -25%
BJCM
41
Blue Jay Capital Management
California
$14.1M +$6.19M +156,450 +78%
TCIM
42
TIAA CREF Investment Management
New York
$13.9M +$983K +24,842 +8%
BIM
43
BlackRock Investment Management
Delaware
$13.8M +$260K +6,565 +2%
Alyeska Investment Group
44
Alyeska Investment Group
Illinois
$13.5M +$2.05M +51,725 +18%
GPP
45
Great Point Partners
Connecticut
$12.9M +$12.9M +325,300 New
EA
46
Emerald Advisers
Pennsylvania
$12.4M +$409K +10,337 +3%
BG
47
BlackRock Group
United Kingdom
$12.3M -$1.85M -46,784 -13%
TCM
48
Tekla Capital Management
Massachusetts
$12.3M – – –
Brown Advisory
49
Brown Advisory
Maryland
$12.2M +$3.2M +81,033 +35%
Allianz Asset Management
50
Allianz Asset Management
Germany
$12M +$3.79M +95,767 +46%
1
2
3 4 5